SOLICITATION NOTICE
R -- Procurement of the USP DI Volume II for access through NLM internet site
- Notice Date
- 3/17/2004
- Notice Type
- Solicitation Notice
- NAICS
- 519190
— All Other Information Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Library of Medicine, 8600 Rockville Pike, Bethesda, MD, 20894
- ZIP Code
- 20894
- Solicitation Number
- NLM-04-095-UHP
- Response Due
- 4/1/2004
- Archive Date
- 4/16/2004
- Point of Contact
- Uyen Phuong, Lead Purchasing Agent, Phone 301 496-6127, Fax 301 402-8169, - Karen Riggs, Contracting Officer, Phone 301 496-6546, Fax 301 402-0642,
- E-Mail Address
-
PHUONGU@mail.nlm.nih.gov, kr33v@nih.gov
- Description
- It is the intent of the national Library of Medicine (NLM) to procure the United States Pharmacopoeia Drug Index (USP DI) Volume II - Information for the Patient for access through MedlinePlus, an NLM internet site. The procurement is intended to be on a sole source basis with Thomson MICROMEDEX, Greenwood Village, Colorado, 80111, for one base year with options for four (4) successive one-year periods. The NLM is developing and managing MedlinePlus, an easily understandable World Wide Web resource to assist consumers in obtaining the information they need to make informed decisions about health care. MedlinePlus links to MEDLINE, the world's largest database of peer-reviewed information, the National Institutes of Health (NIH) consumer health information, clearinghouses, health-related organizations, and clinical trials. In addition to general health topics, MedlinePlus provides access to extensive, authoritative information about specific diseases and conditions ("Health Topics"). The site includes comprehensive and cutting-edge information on over 650 diseases and conditions. The purpose of this procurement is to obtain access to the authoritative, consumer-oriented drug information needed to complement other information available on the site. The USP is the organization that sets the official standards of strength, quality, purity, packaging and labeling for medical products used in the United States. Congress has recognized the USP and the national Formulary as the official U.S. compendia for standards for drugs and for the inactive ingredients in drug dosage forms. The USP DI is the unquestioned American source for independent, authoritative information on drugs marketed in the United States and Canada. Volume I of the USP DI, contains drug use information in technical language for the professional health care provider (e.g. physicians, pharmacists, nurses, etc.). Volume II, the product which the NLM intends to procure, is its lay language counterpart for use by consumers. Thomson MICROMEDEX has been given exclusive rights to market the USP DI, and the product is available only from that source. The proposed acquisition will be procured under FAR Part 12 - Acquisition of Commercial Items. This is not a Request for Quotations (RFQ), nor is an RFQ available, however, all responsible sources may submit a proposal that will be considered by the NLM. Firms interested in responding to this notice must be able to provide service as specified above. Responses must be in writing and must be received in this office within fifteen (15) calendar days from publication date of this notice, and must include pricing information and meet the criteria requirement. Inquires regarding this procurement may be made to the National Library of Medicine, Office of Acquisitions Management, 8600 Rockville Pike, Building 38A, Room B1N20, Bethesda, Maryland 20894, Attention: Uyen H. Phuong, Lead Purchasing Agent, on (301) 496-6127. Fax requests WILL NOT BE ACCEPTED.
- Record
- SN00547854-W 20040319/040317222744 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |